Metoclopramide Injection Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 5 mg/ml
Reference Brands: Maxolon (EU/UK)
Category:
Antiemetic
Metoclopramide Injection is a medicine that is used for the treatment of Nausea And Vomiting Due To Chemotherapy, Radiotherapy And Migraine, Gastritis, Heartburn, Hiccups, Lactation Failure, Heartburn Caused By Gastroesophageal Reflux Disease and other conditions.
Metoclopramide Injection is available in Injection
and strengths such as 5 mg/ml.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Metoclopramide Injection is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Metoclopramide Injection can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Metoclopramide Injection contains Metoclopramide as an active ingredient. Metoclopramide Injection works by controlling vomiting sensations and speeds up emptying of stomach.
Metoclopramide is a dopamine D2 receptor antagonist widely used to manage nausea and vomiting associated with gastroesophageal reflux disease (GERD), diabetic gastroparesis, and chemotherapy. By enhancing gastric motility and accelerating gastric emptying, it helps relieve symptoms of delayed gastric emptying and improves gastrointestinal function. It is also used prophylactically to prevent nausea and vomiting in postoperative patients when nasogastric suction is not feasible.
While primarily approved by the FDA for gastrointestinal motility disorders and chemotherapy-induced nausea, metoclopramide has also demonstrated effectiveness in other conditions such as migraine management, although these uses are considered off-label. Its pharmacological action involves antagonism of dopamine receptors in the chemoreceptor trigger zone and gastrointestinal tract, contributing to both antiemetic and prokinetic effects.
Metoclopramide therapy requires careful monitoring due to potential adverse effects, including extrapyramidal symptoms, tardive dyskinesia, and sedation. Understanding its mechanism of action, appropriate dosing, contraindications, and possible drug interactions is essential for healthcare professionals to optimize patient outcomes while minimizing risks. This makes metoclopramide a valuable option in the clinical management of nausea, vomiting, and gastrointestinal motility disorders.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing